Taken from an email I received informing me of the changes. Overall it looks like a pretty solid update.
Clinical Reference Updates – January 2012 Summary for Medscape App for Androidâ„¢
- 487 diseases & conditions updated
- 114 drug monographs updated
- 4 new drug monographs added
Featured Content of the Month – Heart Failure
This month we bring you an expanded collection of over 30 Heart Failure topics that have been updated with the most recent developments from medical literature and guideline recommendations from the American Heart Association, the New York Heart Association, and the European Society of Cardiology.
Comprehensive coverage on Heart Failure, including:
Echocardiography – discusses the technical aspects of 2-D and Doppler echocardiography and provides an overview of equipment and patient preparation
Transvenous Cardiac Pacing – provides details on obtaining venous access, a technique for placement of the pacing lead, and complications that may occur
Permanent Pacemaker Insertion – offers information on devices and equipment, details on the implantation technique, and a discussion of technical considerations
New Drug Monographsazilsartan/chlorthalidone (Edarbyclor)
New drug combination of an angiotensin II receptor blocker and thiazide-like diuretic indicated for treatment of hypertension.glucarpidase (Voraxaze)
New carboxypeptidase enzyme indicated for toxic plasma methotrexate concentrations in patients with delayed methotrexate clearance due to impaired renal function.
Drug Monograph Updates
A new black box warning was added that describes cases of progressive multifocal leukoencephalopathy, a rare but serious brain infection that can result in death.
Expanded indication includes treatment of acute attacks for laryngeal hereditary angioedema.
New indication for prevention of pneumonia caused by Streptococcus pneumoniae in adults aged 50 years or older.
New pediatric indication for HIV-1 infection in children aged 2 years or older.
New sublingual spray indicated for breakthrough cancer pain.
Our app is continually being updated with new FDA drug approvals, the latest clinical updates from medical literature and current guidelines to help you stay informed and make the best decisions in the treatment of your patients. Here are this month’s featured updates:
Bacterial Pneumonia – Prevnar 13, a pneumococcal 13-valent conjugate vaccine, has been approved by the U.S. Food and Drug Administration for people aged 50 years and older to prevent pneumonia and invasive disease caused by the bacterium, Streptococcus pneumoniae.
